Spine Align Raises $1.75 Million Series Seed Round

Spine Align, a device company developing a portfolio of products that enable spine surgeons to measure, visualize and adjust patients' spinal alignment during surgery, closed a $1.75 million series seed round. Funds will support development and FDA 510(k) clearance for their LiveAlign™ platform in 2021.

LiveAlign leverages image-guided and...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0